In contrast, favorable outcome associated with nuclear survivin has been reported for gastric, bladder, and breast cancers, ependymoma, osteosarcoma and pancreatic ductal adenocarcinoma [43], [44]. Here, BIRC5 is linked to pancreatic ductal adenocarcinoma.